| 282.27 Delayed Data As of Nov 15 |  +7.12 / +2.59%Today’s Change | 215.78 Today|||52-Week Range 344.00 | -6.20% Year-to-Date |
| Here's Why Biogen Stock Shot Up 28% in October Nov 10 / MotleyFool.com - Paid Partner Content | 2 Biotech Stocks Fighting Alzheimer’s Disease to Own Now Nov 09 / MotleyFool.com - Paid Partner Content |
| Better Buy: Biogen vs. Celgene Nov 10 / MotleyFool.com - Paid Partner Content | Biogen's Alzheimer's Drug Goes From Bust to Boon, Plus Why Walgreens Is Shuttering 200 Healthcare Clinics Nov 08 / MotleyFool.com - Paid Partner Content |
| Previous close | 275.15 |
| Today’s open | 278.25 |
| Day’s range | 277.11 - 283.95 |
| Volume | 1,922,192 |
| Average volume (3 months) | 1,841,279 |
| Market cap | $50.9B |
| Earnings growth (last year) | +81.10% |
| Earnings growth (this year) | +26.43% |
| Earnings growth (next 5 years) | +3.00% |
| Revenue growth (last year) | +9.67% |
| P/E ratio | 10.0 |
| Price/Sales | 5.13 |
| Price/Book | 4.27 |
| Today’s change | Today’s % change | |
|---|---|---|
| ILMNIllumina Inc | +7.55 | +2.53% |
| GILDGilead Sciences | +1.26 | +1.97% |
| BMRNBiomarin Pharmaceuti... | -0.54 | -0.71% |
| EXASExact Sciences Corp | +2.81 | +3.55% |
| Next reporting date | January 29, 2020 |
| EPS forecast (this quarter) | $7.92 |
| Annual revenue (last year) | $12.1B |
| Annual profit (last year) | $4.4B |
| Net profit margin | 36.76% |
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Cambridge, Massachusetts |
